COVID-19's Impact On Patient Centricity
By Michael Blackton, Michael Blackton, VP QA CMC at Adaptimmune
Michael Blackton, VP QA CMC and John Lunger Chief Patient Supply Officer at Adaptimmune and I talked about COVID- 19’s impact on the cell and gene sector. You can watch the full-length video here.
For your convenience, I broke down the full-length video question by question. Here, Blackton and Lunger discuss Lunger and Blackton discuss COVID-19’s impact on patient centricity. And, in case you missed it, be sure to_ check out their take on the changes to anticipate in a post-COVID climate.